Reducing Chinese API Imports Key For Indian Pharma Growth, Says IPA
IPA Lays Out ‘Vision 2030’ For Indian Pharma Sector
• By Akriti Seth
The Indian pharma sector fears that policy shifts by the Chinese government could result in extreme price shifts for certain molecules. • Source: Shutterstock
Stay ahead of every shift in generics and biosimilars.
Generics Bulletin brings you the latest updates that matter for the off-patent industry.
